N K Industries Ltd
Incorporated in 1987, NK Industries Ltd manufactures and trading of castor oil
and other allied products and its derivatives[1]
- Market Cap ₹ 40.9 Cr.
- Current Price ₹ 68.0
- High / Low ₹ 98.4 / 48.0
- Stock P/E
- Book Value ₹ -584
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -32.4% over past five years.
- Contingent liabilities of Rs.157 Cr.
- Company has high debtors of 528 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67.10 | 104.37 | 108.06 | 134.06 | 493.13 | 113.72 | 21.97 | 20.33 | 17.77 | 18.06 | 16.11 | 15.94 | |
| 68.25 | 97.69 | 103.68 | 126.94 | 517.40 | 113.96 | 20.26 | 18.17 | 16.46 | 16.67 | 17.86 | 19.35 | |
| Operating Profit | -1.15 | 6.68 | 4.38 | 7.12 | -24.27 | -0.24 | 1.71 | 2.16 | 1.31 | 1.39 | -1.75 | -3.41 |
| OPM % | -1.71% | 6.40% | 4.05% | 5.31% | -4.92% | -0.21% | 7.78% | 10.62% | 7.37% | 7.70% | -10.86% | -21.39% |
| 0.86 | 0.72 | 1.89 | 0.87 | 4.40 | 1.11 | 0.52 | 0.41 | 0.40 | 0.60 | 0.68 | 0.00 | |
| Interest | 0.13 | 0.03 | 0.00 | 0.11 | 0.06 | 0.01 | 0.01 | 0.00 | 0.38 | 0.00 | 0.01 | 0.05 |
| Depreciation | 24.22 | 13.31 | 12.61 | 10.24 | 7.12 | 6.03 | 5.10 | 4.58 | 3.69 | 3.05 | 2.56 | 2.44 |
| Profit before tax | -24.64 | -5.94 | -6.34 | -2.36 | -27.05 | -5.17 | -2.88 | -2.01 | -2.36 | -1.06 | -3.64 | -5.90 |
| Tax % | 0.00% | -26.94% | -23.66% | 36.02% | -31.05% | 21.08% | -21.18% | -24.38% | -21.19% | -2.83% | -2.20% | |
| -24.65 | -4.33 | -4.84 | -3.21 | -18.65 | -6.27 | -2.26 | -1.53 | -1.86 | -1.03 | -3.55 | -5.81 | |
| EPS in Rs | -41.02 | -7.20 | -8.05 | -5.34 | -31.03 | -10.43 | -3.76 | -2.55 | -3.09 | -1.71 | -5.91 | -9.68 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -13% |
| 5 Years: | -32% |
| 3 Years: | -7% |
| TTM: | -15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 7% |
| 3 Years: | % |
| TTM: | -28950% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 30% |
| 3 Years: | 21% |
| 1 Year: | 40% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.01 | 6.01 | 6.01 | 6.01 | 6.01 | 6.01 | 6.01 | 6.01 | 6.01 | 6.01 | 6.01 | 6.01 |
| Reserves | -317.74 | -322.05 | -314.75 | -318.09 | -336.75 | -343.19 | -345.67 | -347.15 | -348.90 | -350.11 | -354.12 | -357.03 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.77 | 0.77 | |
| 670.62 | 637.62 | 637.37 | 2,167.75 | 2,285.96 | 2,240.48 | 2,241.25 | 2,240.47 | 2,240.42 | 2,240.34 | 2,240.64 | 2,241.43 | |
| Total Liabilities | 358.89 | 321.58 | 328.63 | 1,855.67 | 1,955.22 | 1,903.30 | 1,901.59 | 1,899.33 | 1,897.53 | 1,896.24 | 1,893.30 | 1,891.18 |
| 161.66 | 179.08 | 168.29 | 224.71 | 220.50 | 215.88 | 210.78 | 206.62 | 202.99 | 199.97 | 198.31 | 197.07 | |
| CWIP | 1.29 | 0.29 | 2.25 | 5.42 | 5.34 | 4.26 | 5.12 | 6.28 | 6.72 | 6.79 | 6.79 | 6.79 |
| Investments | 0.12 | 0.19 | 0.19 | 0.20 | 0.09 | 0.10 | 0.13 | 0.15 | 0.14 | 0.18 | 0.16 | 0.17 |
| 195.82 | 142.02 | 157.90 | 1,625.34 | 1,729.29 | 1,683.06 | 1,685.56 | 1,686.28 | 1,687.68 | 1,689.30 | 1,688.04 | 1,687.15 | |
| Total Assets | 358.89 | 321.58 | 328.63 | 1,855.67 | 1,955.22 | 1,903.30 | 1,901.59 | 1,899.33 | 1,897.53 | 1,896.24 | 1,893.30 | 1,891.18 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.21 | -21.52 | 4.03 | 4.78 | 13.75 | -9.08 | 3.62 | 1.25 | 0.36 | -0.79 | -3.02 | |
| -2.65 | 16.85 | -2.73 | -1,532.18 | -8.05 | 3.86 | -3.22 | -1.40 | -0.24 | 0.17 | 2.24 | |
| -0.13 | 4.51 | -1.43 | 1,527.41 | -0.06 | -0.01 | -0.01 | 0.00 | -0.38 | 0.00 | 0.76 | |
| Net Cash Flow | 0.42 | -0.16 | -0.14 | 0.02 | 5.64 | -5.22 | 0.38 | -0.15 | -0.26 | -0.63 | -0.01 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 223.68 | 113.45 | 110.15 | 111.14 | 26.12 | 66.76 | 342.07 | 373.98 | 445.52 | 468.68 | 527.68 |
| Inventory Days | 20.33 | 49.98 | 55.99 | 35.23 | 83.11 | ||||||
| Days Payable | 323.78 | 15.47 | 14.50 | 32.96 | 39.69 | ||||||
| Cash Conversion Cycle | -79.77 | 147.96 | 151.63 | 113.41 | 26.12 | 110.18 | 342.07 | 373.98 | 445.52 | 468.68 | 527.68 |
| Working Capital Days | 63.70 | 128.52 | 129.30 | 110.38 | 7.31 | 62.84 | 299.21 | 338.61 | 400.95 | 432.10 | 508.19 |
| ROCE % |
Documents
Announcements
-
Financial Results For The Quarter Ended On 30Th September 2025
10 Nov - Approved unaudited Q2/H1 results to 30 Sep 2025; accumulated losses Rs35,403.93 lakh; legal attachments, auditor qualified.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 10Th November, 2025 For The Quarter Ended On 30 September 2025
10 Nov - Q2/H1 FY2025 results approved; accumulated losses Rs35,403.93 lakh; NSEL/ED/MPID legal actions; auditor qualified.
-
Board Meeting Intimation for 1. To Consider And Approve The Standalone And Consolidated Unaudited Financial Results Of The Company Under Regulation 33 Of Listing Regulations, 2015 For The Quarter Ended On 30Th September, 2025.
3 Nov - Board meeting on 10 Nov 2025 to approve Q2 unaudited results for quarter ended 30 Sep 2025.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Oct
- Shareholding Meeting / Postal Ballot-Scrutinizer''s Report 30 Sep
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Product Profile:
a) Castor Oil:[1]
Commercial Grade Castor oil, Cold Pressed
Castor Oil, Refined Castor Oil, Pale Pressed
Grade Castor Oil, First Pressed Degummed
Castor Oil, Castor Oil BP 93 Grade
b) Derivatives:[2]
Hydrogenated castor Oil, 12-Hydroxy
Stearic Acid (12-H.S.A.) Flakes/ Powder,
Ricinoleic Acid (R.A.)
c) De Oiled Cake:[3]
De Oiled Cake (D.O.C)-Castor Meal,
High Protein Castor Meal (N8/N10)
d) By Products:[4]
Sodium Sulphate Anhydrous, Crude
Glycerin